| 1 | 1390271 | Biological monitoring of exposure to nerve agents. | Br J Ind Med | 1992 Sep |
1 |
| 2 | 8165432 | Action of nerve agents to cholinesterases. | Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove | 1993 |
1 |
| 3 | 31551012 | HOXD-AS1 confers cisplatin resistance in gastric cancer through epigenetically silencing PDCD4 via recruiting EZH2. | Open Biol | 2019 Sep 27 |
11 |
| 4 | 31555430 | The perceptions of natural compounds against dipeptidyl peptidase 4 in diabetes: from <i>in silico</i> to <i>in vivo</i>. | Ther Adv Chronic Dis | 2019 |
2 |
| 5 | 31579066 | MDIG promotes cisplatin resistance of lung adenocarcinoma by regulating ABC transporter expression via activation of the WNT/β-catenin signaling pathway. | Oncol Lett | 2019 Oct |
14 |
| 6 | 31579424 | Multidrug resistance affects the prognosis of primary epithelial ovarian cancer. | Oncol Lett | 2019 Oct |
2 |
| 7 | 31582906 | miR-145 sensitizes esophageal squamous cell carcinoma to cisplatin through directly inhibiting PI3K/AKT signaling pathway. | Cancer Cell Int | 2019 |
13 |
| 8 | 31603446 | A near infrared light-triggered human serum albumin drug delivery system with coordination bonding of indocyanine green and cisplatin for targeting photochemistry therapy against oral squamous cell cancer. | Biomater Sci | 2019 Dec 1 |
2 |
| 9 | 31612051 | Polyphyllin I and VII potentiate the chemosensitivity of A549/DDP cells to cisplatin by enhancing apoptosis, reversing EMT and suppressing the CIP2A/AKT/mTOR signaling axis. | Oncol Lett | 2019 Nov |
12 |
| 10 | 31646806 | Comparisons of efficacy and safety between docetaxel + cisplatin and paclitaxel + cisplatin and their effects on serum HE4, CA125 and ROMA indicators in patients with ovarian carcinoma. | J BUON | 2019 Jul-Aug |
7 |
| 11 | 31653849 | YTHDF1 links hypoxia adaptation and non-small cell lung cancer progression. | Nat Commun | 2019 Oct 25 |
1 |
| 12 | 31661694 | TRIAP1 Inhibition Activates the Cytochrome c/Apaf-1/Caspase-9 Signaling Pathway to Enhance Human Ovarian Cancer Sensitivity to Cisplatin. | Chemotherapy | 2019 |
10 |
| 13 | 31686523 | miR-186-5p targeting SIX1 inhibits cisplatin resistance in non-small-cell lung cancer cells (NSCLCs). | Neoplasma | 2020 Jan |
4 |
| 14 | 31696470 | MiR-203 regulates DJ-1 expression and affects proliferation, apoptosis and DDP resistance of pancreatic cancer cells. | Eur Rev Med Pharmacol Sci | 2019 Oct |
11 |
| 15 | 31702387 | lncRNA <i>UCA1</i> Increases Proliferation and Multidrug Resistance of Retinoblastoma Cells Through Downregulating miR-513a-5p. | DNA Cell Biol | 2020 Jan |
1 |
| 16 | 31707347 | The regulation and interaction of PVT1 and miR181a-5p contributes to the repression of SP1 expression by the combination of XJD decoction and cisplatin in human lung cancer cells. | Biomed Pharmacother | 2020 Jan |
1 |
| 17 | 31709623 | miR-146b Reverses epithelial-mesenchymal transition via targeting PTP1B in cisplatin-resistance human lung adenocarcinoma cells. | J Cell Biochem | 2019 Nov 11 |
8 |
| 18 | 31722522 | Cascade-Reaction-Based Nanodrug for Combined Chemo/Starvation/Chemodynamic Therapy against Multidrug-Resistant Tumors. | ACS Appl Mater Interfaces | 2019 Dec 11 |
1 |
| 19 | 31761329 | NCK1-AS1 promotes NCK1 expression to facilitate tumorigenesis and chemo-resistance in ovarian cancer. | Biochem Biophys Res Commun | 2020 Feb 5 |
5 |
| 20 | 31799659 | MiR-187 influences cisplatin-resistance of gastric cancer cells through regulating the TGF-β/Smad signaling pathway. | Eur Rev Med Pharmacol Sci | 2019 Nov |
13 |
| 21 | 31818312 | m<sup>6</sup>A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis. | J Hematol Oncol | 2019 Dec 9 |
2 |
| 22 | 31827397 | Exosomal lncRNA HNF1A-AS1 affects cisplatin resistance in cervical cancer cells through regulating microRNA-34b/TUFT1 axis. | Cancer Cell Int | 2019 |
5 |
| 23 | 31853314 | miR-31-5p may enhance the efficacy of chemotherapy with Taxol and cisplatin in TNBC. | Exp Ther Med | 2020 Jan |
1 |
| 24 | 31875843 | Depletion of UBE2C reduces ovarian cancer malignancy and reverses cisplatin resistance via downregulating CDK1. | Biochem Biophys Res Commun | 2020 Mar 5 |
2 |
| 25 | 31885310 | miR-29c-3p inhibits autophagy and cisplatin resistance in ovarian cancer by regulating FOXP1/ATG14 pathway. | Cell Cycle | 2020 Jan |
14 |
| 26 | 31892570 | Chronic Stimulation of the Autophagy-inducing Ingredient of Areca Nut Promotes Tumor Growth <i>In Vivo</i> Through Up-regulation of Tumoral Autophagy. | Anticancer Res | 2020 Jan |
2 |
| 27 | 31894841 | NORAD accelerates chemo-resistance of non-small-cell lung cancer via targeting at miR-129-1-3p/SOX4 axis. | Biosci Rep | 2020 Jan 31 |
9 |
| 28 | 31908475 | Knockdown Of lncRNA NCK-AS1 Regulates Cisplatin Resistance Through Modulating miR-137 In Osteosarcoma Cells. | Onco Targets Ther | 2019 |
16 |
| 29 | 31934068 | Amniotic epithelial cells reverse abnormal vascular structure and function in endometrial carcinoma. | Int J Clin Exp Pathol | 2019 |
1 |
| 30 | 31938149 | Knockdown of SALL4 overcomes cisplatin-resistance through AKT/mTOR signaling in lung cancer cells. | Int J Clin Exp Pathol | 2018 |
1 |
| 31 | 31957179 | FGFRL1 affects chemoresistance of small-cell lung cancer by modulating the PI3K/Akt pathway via ENO1. | J Cell Mol Med | 2020 Feb |
1 |
| 32 | 31957833 | LncRNA KCNQ1OT1 contributes to the cisplatin resistance of tongue cancer through the KCNQ1OT1/miR-124-3p/TRIM14 axis. | Eur Rev Med Pharmacol Sci | 2020 Jan |
14 |
| 33 | 31966418 | TGF-β1 gene silencing can enhances the sensitivity of breast cancer to cisplatin partially by restraining the occurrence of EMT. | Int J Clin Exp Pathol | 2017 |
2 |
| 34 | 31966505 | Curcumin combined with cis-platinum promote the apoptosis of human colorectal cancer HT29 cells and mechanism. | Int J Clin Exp Pathol | 2017 |
3 |
| 35 | 31966510 | MicroRNA-146a regulates cisplatin-resistance of non-small cell lung cancer cells by targeting NF-κB pathway. | Int J Clin Exp Pathol | 2017 |
10 |
| 36 | 32016462 | Propofol inhibits proliferation and cisplatin resistance in ovarian cancer cells through regulating the microRNA‑374a/forkhead box O1 signaling axis. | Mol Med Rep | 2020 Mar |
1 |
| 37 | 32052927 | LncRNA MST1P2/miR-133b axis affects the chemoresistance of bladder cancer to cisplatin-based therapy via Sirt1/p53 signaling. | J Biochem Mol Toxicol | 2020 Apr |
16 |
| 38 | 32058824 | Inhibition of autophagy improves resistance and enhances sensitivity of gastric cancer cells to cisplatin. | Can J Physiol Pharmacol | 2020 Jul |
3 |